OraSure Technologies to Present at the JMP Securities Healthcare Conference
17 Giugno 2014 - 12:00PM
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that
Douglas A. Michels, President and CEO, will speak to the investment
community at the JMP Securities Healthcare Conference in New York,
New York. The conference will be simultaneously webcast over the
Internet.
Mr. Michels is scheduled to speak June 24, 2014, at
approximately 10:30 a.m. Eastern Time (7:30 a.m. Pacific Time).
Interested investors can access the live webcast of the
presentation by going to OraSure Technologies' web site,
www.orasure.com, and clicking on the Investor Info link. A replay
of the webcast will be available on OraSure Technologies' web site
for seven days. Alternatively, you can access the live webcast of
the presentation via the following link
http://wsw.com/webcast/jmp24/osur/.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture
and distribution of point of care diagnostic and collection devices
and other technologies designed to detect or diagnose critical
medical conditions. Its innovative products include rapid tests for
the detection of antibodies to HIV and HCV at the point of care and
tests for various drugs of abuse. The Company sells the OraQuick®
In-Home HIV Test, the first and only rapid HIV test approved by the
U.S. Food and Drug Administration for sale to the consumer
over-the-counter market in the U.S. In addition, the Company is a
leading provider of oral fluid sample collection, stabilization and
preparation products for molecular diagnostic applications.
OraSure's portfolio of products is sold globally to various
clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, research and
academic institutions, distributors, government agencies,
physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical
information to patients, empowering them to make decisions to
improve and protect their health.
For more information on OraSure Technologies, please visit
www.orasure.com.
CONTACT: Company contact:
Ronald H. Spair
Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Ott 2023 a Ott 2024